Showing results (21-30 of 115) with videos related to

Sort By:
Pageof 12
Urology|January 1, 1991
Pharmacokinetics and metabolism of nilutamideP J Creaven, L Pendyala, D Tremblay
The Urologic Clinics of North America|May 1, 1984
New potential treatment modalities for disseminated prostatic cancerP J Creaven, S Madajewicz, A Mittelman
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 1, 1993
Evaluation of alpha-difluoromethylornithine as a potential chemopreventive agent: tolerance to daily oral administration in humansP J Creaven, L Pendyala, N J Petrelli
Cancer Chemotherapy and Pharmacology|January 1, 1991
Clinical pharmacokinetics of 3-deazaguanineL Pendyala, P J Creaven, L R Whitfield
Cancer Treatment Reports|March 1, 1982
Studies on the pharmacokinetics and metabolism of cis-dichloro-trans-dihydroxy-bis-isopropylamine platinum(IV) in the dogL Pendyala, J W Cowens, P J Creaven
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 1, 1993
Urinary and erythrocyte polyamines during the evaluation of oral alpha-difluoromethylornithine in a phase I chemoprevention clinical trialL Pendyala, P J Creaven, C W Porter
The Journal of Prosthetic Dentistry|March 1, 1980
Surface roughness of two dental amalgams after various polishing techniquesP J Creaven, J B Dennison, G T Charbeneau
American Journal of Clinical Oncology|April 16, 1998
Octreotide does not prevent diarrhea in patients treated with weekly 5-fluorouracil plus high-dose leucovorinN J Meropol, L E Blumenson, P J Creaven
Cancer|April 1, 1978
Intrathecal methotrexate overdose without neurotoxicity: case report and literature reviewL J Ettinger, A I Freeman, P J Creaven
Cancer Chemotherapy and Pharmacology|January 1, 1989
Phase II trial of continuous-infusion iproplatin (CHIP) and 5-fluorouracil (5-FU) in advanced colorectal carcinomaN J Petrelli, P J Creaven, L Herrera, et al.
Pageof 12